Albany Molecular Research Incorporated operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Albany Molecular Research Incorporated with three other
companies in this sector in the United States:
Five Prime Therapeutics Inc
sales of $379.80 million
Insys Therapeutics Incorporated
of which 100%
was Non-Drug Products), and
Medpace Holdings Inc
Albany Molecular Research Incorporated reported sales of $402.36 million
December of 2015.
increase of 45.5%
versus 2014, when the company's sales were $276.57 million.
Sales at Albany Molecular Research Incorporated have increased during each of the previous five years
(and since 2010, sales have increased a total of 103%).
Sales of Drug Products saw an increase
that was more than double the company's growth rate: sales were up
203.5% in 2015, from
$29.62 million to $89.90 million.